Thrombogenicity and endothelial progenitor cells function during Acute myocardial infarction - comparison of Prasugrel versus Ticagrelor.
Maya WiessmanMark KheifetsNili Schamroth PravdaDorit Leshem LevEti ZivRan KornowskiGalia SpectreLeor PerlPublished in: Journal of thrombosis and thrombolysis (2023)
Among STEMI patients, prasugrel as compared to ticagrelor was associated with more potent TG inhibition and improved EPCs count and function.
Keyphrases
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- atrial fibrillation
- peritoneal dialysis
- heart failure
- left ventricular
- endothelial cells